Cartilage Degeneration Market Global Analysis & Forecast - 2027
The cartilage degeneration market is expected to reach US$ 14,580.10 million in 2027 from US$ 10,459.93 million in 2019. The market is estimated to grow with a CAGR of 4.4% from 2020-2027.
Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.The global cartilage degeneration market is driven by factors such as growing number of sports injuries, and increasing prevalence of obesity. However, the high cost of cartilage repair hampers the market growth. Additionally, growing number of product approvals and developments are creating growth opportunities for the market players.
Market Insights
Increasing Prevalence of Obesity
Obesity has a considerable effect on the musculoskeletal system, resulting into degeneration of bones, cartilage, and ligaments. Moreover, the condition, along with other prominent factors, is strongly allied with the increased risk of rapid cartilage loss. The growing prevalence of obesity is likely to accelerate the incidence of cartilage degeneration, which will drive the market growth.
According to the study published by the World Health Organization (WHO) in 2020, the frequency of obesity among the worldwide population has tripled since 1975. Furthermore, according to the same study, 38 million children below 5 years of age were overweight in 2019 worldwide. This massive prevalence of obesity is likely to accelerate due to unhealthy lifestyles such as consumption of junk food, sedentary lifestyle, genetic conditions, and deprivation of mental health. For instance, according to a study published by the Centers of Disease Control and Prevention, the prevalence of obesity grew from 30.5% to 42.4% during past two decades in the US. Overweight conditions among players and athletes can lead to the increasing prevalence of sports injuries. For instance, according to a study published in the British Journal of Sports Medicine in 2015, athletes with BMI index more than 30 kg/m2 are highly susceptible generationto the sports injuries. Such association between obesity and cartilage degeneration is anticipated to drive the market growth by 2027.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cartilage Degeneration Market: Strategic Insights
Market Size Value in US$ 10,459.93 Million in 2019 Market Size Value by US$ 14,580.10 Million by 2027 Growth rate CAGR of 4.4% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cartilage Degeneration Market: Strategic Insights
| Market Size Value in | US$ 10,459.93 Million in 2019 |
| Market Size Value by | US$ 14,580.10 Million by 2027 |
| Growth rate | CAGR of 4.4% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Application Insights
Based on application, the cartilage degeneration market is segmented into knee, hip, and other applications. In 2019, the knee segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to study published on online newspaper, which is based on NCBI data, an estimated 1 in 4 adults suffer from chronic knee pain. Moreover, the prevalence of knee pain has witnessed massive growth of around 40.0% during past 4 decades. Furthermore, increasing awareness of benefits provided by cartilage repair is also anticipated to drive the growth of knee segment.
Procedure Type Insights
The cartilage degeneration market, by procedure type, is segmented into osteochondral transplant, chondroplasty, joint replacement, meniscus transplants, cell-based cartilage resurfacing, and other procedure types. The joint replacement segment held the largest share of the market in 2019, whereas the cell-based cartilage resurfacing segment is anticipated to register the highest CAGR in the market during the forecast period.
End User Insights
Based on end user, the cartilage degeneration market is segmented into hospitals and specialty clinics, ambulatory surgical centers and,academic & research institutes. The hospitals and specialty clinicssegment held the largest share of the market in 2019. Also, the segment is estimated to register the highest CAGR in the market during the forecast period.
Product launches and approvalsare the commonly adopted strategies by companies to expand their global footprintsand product portfoliostomeet the growing consumer demand. The cartilage degeneration marketplayers adopt the collaborationsstrategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
Cartilage Degeneration Market Report Scope
Global Cartilage degeneration market– ByProcedure type
- Osteochondral Transplant
- Chondroplasty
- Joint Replacement
- Meniscus Transplants
- Cell-based Cartilage Resurfacing
- Others Procedures
Global Cartilage degeneration market– By Application
- Knee
- Hip
- Other Applications
Global Cartilage degeneration market– By End User
- Hospitals and Specialty
- Clinics, Ambulatory Surgical Centres
- Academic and Research Institutes
Cartilage degeneration market– By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Zimmer Biomet
- CartiHeal Inc.
- Vericel Corporation
- Depuy Synthes
- Anika Therapeutics, Inc.
- Conmed Corporation
- Arthrex,Inc.
- B. Braun Melsungen AG
- Stryker
- Smith and Nephew Plc..
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Procedure Type ; Application End User ; and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
On the basis of end user, the cartilage degeneration market is segmental into hospitals and specialty clinics, ambulant surgical centers and, educational & research institutes. The hospitals and specialty clinics section command the biggest share of the market in 2019.
The cartilage degeneration market is growing at CAGR of 4.4%
Among others, APAC region is growing at CAGR of 5% in cartilage degeneration market
The major growth driving factors of cartilage degeneration market are increasing number of sports injuries, and growing prevalence of obesity.
Anika Therapeutics Inc., B. Braun Melsungen AG, CartiHeal Inc., Smith and Nephew Plc., Depuy Synthes, Zimmer Biomet, Vericel Corporation, Arthrex Inc., Conmed Corporation, Stryker, amongst others are a number of the leading corporations operational within the cartilage degeneration market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cartilage Degeneration Market – By Procedure Type
1.3.2 Global Cartilage Degeneration Market – By Application
1.3.3 Global Cartilage Degeneration Market – By End User
1.3.4 Global Cartilage Degeneration market – By Geography
2. Cartilage Degeneration Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Cartilage Degeneration – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.1 Expert Opinions
4.2 Microfracturing and Arthroplasty Procedures, 2019
5. Cartilage Degeneration Market– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Sports Injuries
5.1.2 Increasing Prevalence of Obesity
5.2 Key Market Restraints
5.2.1 High Cost of Cartilage Repair Therapies
5.3 Key Market Opportunities
5.3.1 Growing Number of Product Approvals and Developments
5.4 Future Trends
5.4.1 Rising Emphasis on Regenerative Medicines
5.5 Impact analysis
6. Cartilage Degeneration Market – Global Analysis
6.1 Global Cartilage Degeneration Market Revenue Forecast And Analysis
6.2 Global Cartilage Degeneration Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Cartilage Degeneration Market Analysis – By Procedure Type
7.1 Overview
7.2 Cartilage Degeneration Market Revenue Share, by Procedure Type (2019 and 2027)
7.3 Osteochondral Transplant
7.3.1 Overview
7.3.2 Osteochondral Transplant: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Chondroplasty
7.4.1 Overview
7.4.2 Chondroplasty: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Joint Replacement
7.5.1 Overview
7.5.2 Joint Replacement: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Meniscus Transplants
7.6.1 Overview
7.6.2 Meniscus Transplants: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Cell-based Cartilage Resurfacing
7.7.1 Overview
7.7.2 Cell-Based Cartilage Resurfacing: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Other Procedures
7.8.1 Overview
7.8.2 Other Procedures: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
8. Cartilage Degeneration Market Analysis – By Application
8.1 Overview
8.2 Cartilage Degeneration Market Revenue Share, by Application (2019 and 2027)
8.3 Knee
8.3.1 Overview
8.3.2 Knee: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Hip
8.4.1 Overview
8.4.2 Hip: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Other Applications
8.5.1 Overview
8.5.2 Other Applications: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
9. Cartilage Degeneration Market Analysis – By End User
9.1 Overview
9.2 Cartilage Degeneration Market Share, by End User, 2019 and 2027, (%)
9.3 Hospitalsand Specialty Centres
9.3.1 Overview
9.3.2 Hospitals and Specialty Centres: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 Ambulatory Surgical Centres: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
10. Cartilage Degeneration Market – Geographic Analysis
10.1 North America: Cartilage Degeneration Market
10.2 Overview
10.2.1 North America: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.2.2 North America: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)
10.2.3 North America: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)
10.2.4 North America: Cartilage Degeneration Market, by End User, 2018–2027 (USD Million)
10.2.5 North America: Cartilage Degeneration Market, by Country, 2019& 2027 (%)
10.2.6 US: Cartilage Degeneration Market– Revenue and Forecast to 2027 (USD Million)
10.2.6.1 US: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.2.6.2 US: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)
10.2.6.3 US: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)
10.2.6.4 US: Cartilage Degeneration Market, by End User , 2018–2027 (USD Million)
10.2.7 Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Canada: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)
10.2.7.3 Canada: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)
10.2.7.4 Canada: Cartilage Degeneration Market, by End User , 2018–2027 (USD Million)
10.2.8 Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 Mexico Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 Mexico Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 Mexico Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3 Europe: Cartilage Degeneration Market
10.3.1 Overview
10.3.2 Europe: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.3 Europe: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.3.4 Europe: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.3.5 Europe: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.3.6 Europe: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
10.3.7 Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 Germany: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.3.7.3 Germany: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.3.7.4 Germany: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.3.8 France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 France: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.3.8.3 France: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.3.8.4 France: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.3.9 UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 UK: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.3.9.3 UK: Cartilage Degeneration Market, Application – Revenue and Forecast to 2027 (USD Million)
10.3.9.4 UK: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.3.10 Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 Italy: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.3.10.3 Italy: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.3.10.4 Italy: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.3.11 Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Spain: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.3.11.3 Spain: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.3.11.4 Spain: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.4 Asia Pacific: Cartilage Degeneration Market
10.4.1 Overview
10.4.2 Asia Pacific: Cartilage Degeneration Market - Revenue and Forecast to 2027 (USD Million)
10.4.3 Asia Pacific: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.4.4 Asia Pacific: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.4.5 Asia Pacific: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.4.6 Asia Pacific: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
10.4.7 China: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 China: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 China: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 China: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.4.7.4 China: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.4.8 Japan: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 Japan: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 Japan: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 Japan: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.4.8.4 Japan: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.4.9 India: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 India: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 India: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 India: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.4.9.4 India: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.4.10 South Korea: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.1 South Korea: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.2 South Korea: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.4.10.3 South Korea: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.4.10.4 South Korea: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.4.11 Australia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.11.1 Australia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.4.11.2 Australia: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.4.11.3 Australia: Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
10.4.11.4 Australia: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
10.5 Middle East & Africa: Cartilage Degeneration Market
10.5.1 Overview
10.5.2 Middle East & Africa: Cartilage Degeneration Market - Revenue and Forecast to 2027 (US$ Million)
10.5.3 Middle East & Africa Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.5.4 Middle East & Africa Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.5 Middle East & Africa Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.6 Middle East & Africa: Cartilage Degeneration Market, by Country, 2019& 2027 (%)
10.5.7 Saudi Arabia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Saudi Arabia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Saudi Arabia Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Saudi Arabia Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Saudi Arabia Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.8 UAE: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 UAE: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 UAE Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 UAE Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 UAE Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.9 South Africa: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.1 South Africa: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.2 South Africa Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.5.9.3 South Africa Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.5.9.4 South Africa Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.6 South and Central America: Cartilage Degeneration Market
10.6.1 Overview
10.6.2 South and Central America: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.6.3 South and Central America Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.6.4 South and Central America Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.6.5 South and Central America Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.6.6 South and Central America: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
10.6.7 Brazil: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.6.7.1 Brazil: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.6.7.2 Brazil Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.6.7.3 Brazil Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.6.7.4 Brazil Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.6.8 Argentina: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.6.8.1 Argentina: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.6.8.2 Argentina Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.6.8.3 Argentina Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.6.8.4 Argentina Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Cartilage Degeneration Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of World: Impact Assessment of COVID-19 Pandemic
12. Cartilage Degeneration Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Zimmer Biomet
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 B. Braun Melsungen AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Stryker Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Smith & Nephew
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 CartiHeal, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CONMED Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Anika Therapeutics, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Arthrex, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Vericel Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Microfracturing and Arthroplasty Procedures, 2019 (In Thousands)
Table 2. North America Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Cartilage Degeneration Market, by Application, – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. US Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 6. US Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 7. US Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 16. Europe: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 19. Germany: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 20. France: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 21. France: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 22. France: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 23. UK: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 24. UK: Cartilage Degeneration Market, Application – Revenue and Forecast to 2027 (USD Million)
Table 25. UK: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 26. Italy: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 27. Italy: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 28. Italy: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 29. Spain: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 30. Spain: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 31. Spain: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 32. Asia Pacific: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 33. Asia Pacific: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 34. Asia Pacific: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 35. China: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 36. China: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 37. China: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 38. Japan: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Japan: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 40. Japan: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 41. India: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 42. India: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 43. India: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 46. South Korea: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 47. Australia: Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 48. Australia: Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million).
Table 49. Australia: Cartilage Degeneration Market, End User – Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East & Africa Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East & Africa Cartilage Degeneration Market, byApplication– Revenue and Forecast to 2027 (USD Million)
Table 52. Middle East & Africa Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 55. Saudi Arabia Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 58. UAE Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 61. South Africa Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 64. South and Central America Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 67. Brazil Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 70. Argentina Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 71. Organic Developments Done By Companies
Table 72. Inorganic Developments Done By Companies
Table 73. Glossary of Terms, Cartilage Degeneration Market
LIST OF FIGURES
Figure 1. Cartilage Degeneration Market Segmentation
Figure 2. Cartilage Degeneration Market Segmentation, By Region
Figure 3. Cartilage Degeneration Market Overview
Figure 4. Knee ApplicationSegment Held Largest Share of Cartilage Degeneration Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Cartilage Degeneration Market, by Geography (US$ Million)
Figure 7. Global Cartilage Degeneration Market – Leading Country Markets (US$ Million)
Figure 8. Global Cartilage Degeneration Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Cartilage Degeneration Market Impact Analysis of Driver and Restraints
Figure 15. Global Cartilage Degeneration Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Cartilage Degeneration Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Cartilage Degeneration Market
Figure 18. Cartilage Degeneration Market Revenue Share, by Procedure Type (2019 and 2027)
Figure 19. Osteochondral Transplant: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Chondroplasty: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Joint Replacement: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Meniscus Transplants: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Cell-Based Cartilage Resurfacing: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Other Procedures: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Cartilage Degeneration Market Revenue Share, by Application (2019 and 2027)
Figure 26. Knee: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Hip: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Other Applications: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cartilage Degeneration Market Share, by End User, 2019 and 2027 (%)
Figure 30. Hospitals and Specialty Centers: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Ambulatory Surgical Centers: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Academic and Research Institutes: Cartilage Degeneration Market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 34. North America Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
Figure 36. US: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 40. Europe: Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 41. Europe: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
Figure 42. Germany: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 43. France: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. UK: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. Italy: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. Spain: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia Pacific: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 48. Asia Pacific: Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 49. Asia Pacific: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
Figure 50. China: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 51. Japan: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 52. India: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. South Korea: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. Australia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Middle East & Africa: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 56. Middle East & Africa Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Cartilage Degeneration Market, by Country, 2019& 2027 (%)
Figure 58. Saudi Arabia: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 59. UAE: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. South Africa: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 62. South and Central America Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 66. Impact of COVID-19 Pandemic in North American Country Markets
Figure 67. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 68. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 69. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 70. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Cartilage Degeneration Market
- Zimmer Biomet
- CartiHeal Inc.
- Vericel Corporation
- Depuy Synthes
- Anika Therapeutics, Inc.
- Conmed Corporation
- Arthrex,Inc.
- B. Braun Melsungen AG
- Stryker
- Smith and Nephew Plc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For